Three studies, published in JAMA Internal Medicine, looked at the drug Tocilizumab to treat COVID-19 patients. Prof Martin Landray, … read more
A preprint, an unpublished non peer-reviewed study, from the World Health Organisation (WHO) and reported by the FT, looked at … read more
The pharmaceutical company Lilly have made an announcement on the progress of research into their neutralising antibodies treatment for COVID-19. … read more
Research, published in the Lancet, reports on the use of lopinavir–ritonavir in treating hospitalised patients with COVID-19. Prof Stephen … read more
Research, published in Gut, looked at proton pump inhibitors (PPIs) and type-2 diabetes. Prof Naveed Sattar, Professor of Metabolic Medicine, … read more
It has been announced that the UK RECOVERY trial will be starting investigations into a new possible treatment for COVID-19, … read more
A study, published in PLOS Medicine, looked at Non-steroidal anti-inflammatory drugs (NSAIDs) and severity of COVID-19. Dr Rupert Payne, Consultant … read more
The National Institute of Health and Care Excellence (NICE) have announced a second public consultation on its draft guidance which … read more
A meta-analysis of seven randomised controlled trials which looked at whether corticosteroids are effective in reducing deaths among people most … read more
A meta analysis, published in JAMA, looked at seven trials of corticosteroids for the treatment of severe COVID-19 symptoms, and the … read more
The government have announced new measures to support the deployment if COVID-19 vaccines along side a consultation on amending the … read more
A study, published in Current Atherosclerosis Reports, looked at the relationship between blood pressure medicines and COVID-19. Prof Stephen … read more
A study, published in the New England Journal of Medicine, looked at the drug ofatumumab for multiple sclerosis in a phase … read more
An analysis, published in BMJ Evidence Based Medicine, looked at clinical trial data on cholesterol lowering drugs and targets for ‘bad’ … read more
A study, published in the BMJ, looked at remdesivir in hospitalised severe COVID-19 patients. Prof Stephen Evans, Professor of Pharmacoepidemiology, … read more
A study, published in Nature, looked at a large-scale screen of potential anti-SARS-CoV-2 drugs. Dr Stephen Griffin, Associate Professor … read more
The UK drug company Synairgen, founded by academics from the University of Southampton, have announced in a press release that … read more
The pharmaceutical company Gilead have released additional data about the drug remdesivir for the treatment of COVID-19, including data on … read more
It has been reported that the US are buying up large stocks of the drug remdesivir, which has preliminarily shown … read more
NHS England have announced that UK patients will be able to access a new treatment for Cystic Fibrosis, combing the … read more
